Sign up
Pharma Capital

Concepta raises £2mln to fund China expansion

Erik Henau, chief executive of Concepta plc (LON:CPT), tells Proactive they've conditionally raised £2mln in an over-subscribed share placing as well as received formal sign-off today on a £600,000 Chinese deal.

The proceeds of the raise will be used to fund the fertility specialist's expansion in the People’s Republic, though some of the cash will be invested in new product development.

 

View full CPT profile

Concepta Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.